Repository
How to publish
Resources
FAQs

Show simple item record

The rheumatology drugs for COVID-19 management: which and when?

dc.contributor.authorAtzeni, Fabiola
dc.contributor.authorMasala, Ignazio Francesco
dc.contributor.authorRodríguez Carrio, Javier 
dc.contributor.authorRíos Garces, Roberto
dc.contributor.authorGerratana, Elisabetta
dc.contributor.authorLa Corte, Laura
dc.contributor.authorGiallanza, Manuela
dc.contributor.authorNucera, Valeria
dc.contributor.authorRiva, Agostino
dc.contributor.authorEspinosa, Gerard
dc.contributor.authorCervera, Ricard
dc.date.accessioned2021-07-26T07:51:28Z
dc.date.available2021-07-26T07:51:28Z
dc.date.issued2021
dc.identifier.citationJournal of Clinical Medicine, 10(4), (2021); doi:10.3390/jcm10040783
dc.identifier.urihttp://hdl.handle.net/10651/60145
dc.language.isoeng
dc.relation.ispartofJournal of Clinical Medicine
dc.rights© 2021 Los autores
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceWOS:000623968100001
dc.titleThe rheumatology drugs for COVID-19 management: which and when?
dc.typejournal article
dc.identifier.doi10.3390/jcm10040783
dc.relation.publisherversionhttp://dx.doi.org/10.3390/jcm10040783
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Files in this item

untranslated
Name:
jcm-10-00783-v3.pdf
Size:
629.0Kb
Format:
PDF
Description:
Versión de la editorial

This item appears in the following Collection(s)

Show simple item record

© 2021 Los autores
This item is protected with a Creative Commons License